tradingkey.logo
tradingkey.logo
Suchen

Ekso Bionics Holdings Inc

EKSO
Zur Watchlist hinzufügen
11.800USD
0.0000.00%
Trading geöffnet ETKurse um 15 Minuten verzögert
3.20BMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Ekso Bionics Holdings Inc Unternehmen

Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.

Ekso Bionics Holdings Inc Informationen

BörsenkürzelEKSO
Name des UnternehmensEkso Bionics Holdings Inc
IPO-datumApr 10, 2013
CEODavis (Scott G)
Anzahl der mitarbeiter61
WertpapierartOrdinary Share
GeschäftsjahresendeApr 10
Addresse101 Glacier Point
StadtSAN RAFAEL
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl94901
Telefon15109841761
Websitehttps://eksobionics.com/
BörsenkürzelEKSO
IPO-datumApr 10, 2013
CEODavis (Scott G)

Führungskräfte von Ekso Bionics Holdings Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jerome Wong
Mr. Jerome Wong
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
67.10K
+59.61%
Ms. Mary Ann Cloyd
Ms. Mary Ann Cloyd
Independent Director
Independent Director
30.45K
+17.12%
Mr. Jason C. Jones
Mr. Jason C. Jones
Chief Operating Officer
Chief Operating Officer
25.27K
+26.45%
Ms. Deborah Lafer Scher
Ms. Deborah Lafer Scher
Independent Director
Independent Director
5.21K
-201.96%
Mr. Steven A. Sherman
Mr. Steven A. Sherman
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Dr. Charles Li, Ph.D.
Dr. Charles Li, Ph.D.
Independent Director
Independent Director
--
--
Dr. Corinna E. Lathan
Dr. Corinna E. Lathan
Independent Director
Independent Director
--
--
Mr. Scott G. Davis
Mr. Scott G. Davis
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Stephen Kilmer
Mr. Stephen Kilmer
Investor Relations
Investor Relations
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jerome Wong
Mr. Jerome Wong
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
67.10K
+59.61%
Ms. Mary Ann Cloyd
Ms. Mary Ann Cloyd
Independent Director
Independent Director
30.45K
+17.12%
Mr. Jason C. Jones
Mr. Jason C. Jones
Chief Operating Officer
Chief Operating Officer
25.27K
+26.45%
Ms. Deborah Lafer Scher
Ms. Deborah Lafer Scher
Independent Director
Independent Director
5.21K
-201.96%
Mr. Steven A. Sherman
Mr. Steven A. Sherman
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Dr. Charles Li, Ph.D.
Dr. Charles Li, Ph.D.
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Ekso Bionics Holdings Inc?

Die fünf größten Anteilseigner von Ekso Bionics Holdings Inc sind: Mr. Jerome Wong

Wie viele Institutionen halten Anteile an Ekso Bionics Holdings Inc (EKSO)?

Mit Stand vom 2026Q1 halten 66 Institutionen Anteile an Ekso Bionics Holdings Inc, mit einem Gesamtmarktwert von etwa 972.39K, was 3.28% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 491581.00 gestiegen.